Potency of nucleoside analogs against Powassan virus replication and identification of 4'-fluorouridine as a therapeutic candidate for tick-borne orthoflavivirus encephalitis
Lewis, D. S. M.; Moore, T.; Patel, R.; Cox, R.
Show abstract
Powassan virus (POWV) is an emerging tick-borne orthoflavivirus that causes severe encephalitis, long-term neurologic sequelae, and death, yet no approved antiviral therapies exist. Here, we evaluated several previously characterized nucleoside analogs as candidate countermeasures for POWV encephalitis. Favipiravir, molnupiravir, 4'-fluorouridine (4'-FlU), and GS-441524 inhibited POWV replication in vitro and demonstrated comparable activity against West Nile virus (WNV). We established C3H/HeNCrl mice as a stringent POWV disease model, showing increased susceptibility, higher day 7 brain titers, and more pronounced neurologic signs resembling severe human disease, compared with C57BL/6 mice. In prophylactic and therapeutic studies, 4'-fluorouridine was the most efficacious compound tested, significantly reducing brain viral burden even when treatment was delayed. Direct comparison with molnupiravir, favipiravir, and GS-441524 in mice confirmed superior survival benefit and antiviral activity for 4'-FlU against both POWV and WNV. These data identify 4'-fluorouridine as a promising therapeutic candidate for neurotropic flavivirus disease.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Bemnifosbuvir and remdesivir inhibit tick-borne encephalitis virus infection in complementary in vitro and ex vivo disease models 97%
- Combinations of approved oral nucleoside analogues confer potent suppression of alphaviruses in vitro and in vivo 95%
- Identification of novel Ebola virus inhibitors using biologically contained virus 94%
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- Characterization of the First Complete Genome Sequence of Yellow Fever Virus (YFV) isolate in Sierra Leone: Implications for Public Health 94%
- A human ex vivo dengue virus neutralization assay identifies priority antibodies and epitopes for vaccines and therapeutics. 93%
- AT-752, a double prodrug of a guanosine nucleotide analog, inhibits yellow fever virus in a hamster model 93%
Similar papers in this journal
- A novel antiviral formulation inhibits a range of enveloped viruses. 92%
- Newly identified genomic sequences establish benchmarks for proposed taxonomic classification of jingmenviruses 92%
- Combined computational and cellular screening identifies synergistic inhibition of SARS-CoV-2 by lenvatinib and remdesivir 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.